Article 27 of Delegated Regulation (EU) 2020/687 provides, amongst other things, for prohibitions on movements of animals and products in the protection zone. Paragraph 3 of that Article allows for certain products to be exempted from that prohibition. An exemption is only possible for products that are safe and do not present a risk for the transmission of category A diseases to terrestrial animals. Paragraph 3 lists derived products as one such product. However, derived products may, in accordance with the rules on animal by-products, and in particular Commission Regulation (EU) No 142/2011 [Commission Regulation (EU) No 142/2011 of 25 February 2011 implementing Regulation (EC) No 1069/2009 of the European Parliament and of the Council laying down health rules as regards animal by-products and derived products not intended for human consumption and implementing Council Directive 97/78/EC as regards certain samples and items exempt from veterinary checks at the border under that Directive (OJ L 54, 26.2.2011, p. 1, ELI: http://data.europa.eu/eli/reg/2011/142/oj).] be treated by different methods and some of those methods may not be sufficient to mitigate the risk of a category A disease in terrestrial animals. Recent experiences with the application of disease control measures in the Union have highlighted that deficiency. It is, therefore, necessary to amend Delegated Regulation (EU) 2020/687 so as to require those treatments for the relevant derived products, as provided for in Regulation (EU) No 142/2011, which are considered to mitigate the risk of pathogens of those category A diseases. In addition, gelatine and collagen as defined in Annex I, points 7.7 and 7.8 to Regulation (EC) No 853/2004 of the European Parliament and of the Council [Regulation (EC) No 853/2004 of the European Parliament and of the Council of 29 April 2004 laying down specific hygiene rules for food of animal origin (OJ L 139, 30.4.2004, p. 55, ELI: http://data.europa.eu/eli/reg/2004/853/oj).] are, due to their production process, considered to be products of animal origin which do not represent a risk as regards transmissible animal diseases falling within the scope of Regulation (EU) 2016/429. It is, therefore, necessary to exempt gelatine and collagen from the prohibitions provided for in Article 27(1) and (2) of Delegated Regulation (EU) 2020/687. Therefore, Article 27(3) of Delegated Regulation (EU) 2020/687 should be amended accordingly. Furthermore, as consequence to the amendments in Article 27(3), Articles 33(1) and 49(1) should be revised to refer to the part of Annex VII to Delegated Regulation (EU) 2020/687 where the risk mitigating treatments for those products are laid down.
Recital 10, Regulation (EU) 2026/322
In forcesince 12 Feb 2026
Regulation (EC) No 853/2004 of the European Parliament and of the Council of 29 April 20…Law
Regulation (EC) No 1069/2009 of the European Parliament and of the Council of 21 October…Law
Commission Regulation (EU) No 142/2011 of 25 February 2011 implementing Regulation (EC)…Law
- celex=31997L0078
- celex=32002R1774
- num:eu=1997/78